betamethasone has been researched along with 1 alpha,24-dihydroxyvitamin d3 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Kanai, Y; Koizumi, T; Komoriya, K; Matsuda, S; Matsui, T; Nakagawa, T; Nakao, Y | 1 |
| Fukuoka, M; Komoriya, K; Ogino, Y; Ohta, T; Sato, H | 1 |
| Goodfield, M; Kaufmann, R; Lecha, M; Ortonne, JP | 1 |
| Guignard, E; Ortonne, JP; Peeters, P; Sitbon, R | 1 |
| Curčić, D; Gupta, A; Langley, RG; Papp, K; Wexler, D; Østerdal, ML | 1 |
| Calzavara-Pinton, P; Rossi, MT; Sala, R; Venturini, M | 1 |
| Cassano, N; Neri, L; Vena, GA | 1 |
4 trial(s) available for betamethasone and 1 alpha,24-dihydroxyvitamin d3
| Article | Year |
|---|---|
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Calcitriol; Confidence Intervals; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Psoriasis; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2004 |
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Confidence Intervals; Cost-Benefit Analysis; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Costs; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ointments; Probability; Psoriasis; Reference Values; Risk Factors; Severity of Illness Index; Treatment Outcome | 2005 |
Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Dihydroxycholecalciferols; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Ointment Bases; Pharmaceutical Vehicles; Psoriasis; Severity of Illness Index; Treatment Outcome | 2011 |
The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Budesonide; Calcitriol; Dermatologic Agents; Dihydroxycholecalciferols; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ointments; Pruritus; Psoriasis; Time Factors; Young Adult | 2011 |
3 other study(ies) available for betamethasone and 1 alpha,24-dihydroxyvitamin d3
| Article | Year |
|---|---|
Effects of corticosteroid and 1,24R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Antigens, Ly; Autoimmune Diseases; Betamethasone; Dihydroxycholecalciferols; Lymphocyte Activation; Lymphocytes; Lymphoid Tissue; Male; Mice; Mice, Mutant Strains | 1985 |
Regulation of RANTES and IL-8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol).
Topics: Betamethasone; Cells, Cultured; Chemokine CCL5; Cyclosporine; Dihydroxycholecalciferols; Fibroblasts; Humans; Interleukin-8; Skin | 1998 |
Prescription size and adherence in the management of psoriasis: is the more, the better?
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Attitude of Health Personnel; Betamethasone; Calcitriol; Clobetasol; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Drug Prescriptions; Gels; Humans; Immunosuppressive Agents; Medication Adherence; Practice Patterns, Physicians'; Psoriasis | 2014 |